Hospice admission of cancer patients receiving disease-modifying therapies near the end of life: implications for eligibility criteria
Carla Bettini, Andrea Carlini, Laura Fabbri, Francesca Ghetti et autres
0 citationsTumori Journal
Francesca Martini
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
113Publications signalées
2994Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Chronic Lymphocytic Leukemia ResearchInflammatory Biomarkers in Disease PrognosisPlatelet Disorders and TreatmentsVenous Thromboembolism Diagnosis and ManagementAdipokines, Inflammation, and Metabolic Diseases
Publications récentes
Unveiling the phase behavior of type–II choline chloride/calcium chloride hexahydrate/water deep eutectic solvents via thermal and solid state NMR characterization
Giulio Giannessi, Gianluca Ciancaleoni, Celia Duce, Chiara Pelosi et autres
1 citationJournal of Molecular Liquids
Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.
Thomas Chatzikonstantinou, Persefoni Talimtzi, Eva Minga, Maria K. Angelopoulou et autres
0 citationsBlood
Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.
Thomas Chatzikonstantinou, Persefoni Talimtzi, Eva Minga, Maria K. Angelopoulou et autres
0 citationsBlood
Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, Persefoni Talimtzi et autres
0 citationsBlood
EXABS-205-CLL: Data From NGS: What to Do With Additional Abnormalities Found at Diagnosis
Fabrizio Mavilia, Francesca Martini, Lydia Scarfò
0 citationsClinical Lymphoma Myeloma & Leukemia
Loss of CYLD promotes splenic marginal zone lymphoma
Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, Ferdinando Bonfiglio et autres
2 citationsHemaSphere
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience
Idanna Innocenti, Annamaria Tomasso, Diana Giannarelli, Lydia Scarfò et autres
3 citationsHematological Oncology
Author response for "Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience"
Idanna Innocenti, Annamaria Tomasso, Diana Giannarelli, Lydia Scarfò et autres
0 citations
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
Idanna Innocenti, Antonio Mosca, Annamaria Tomasso, Andrea Galitzia et autres
4 citationsHemaSphere
Acalabrutinib in High-Risk Chronic Lymphocytic Leukemia Patients Naïve or Previous Treated. a Multicenter Retrospective Observational Real-Life Experience
Idanna Innocenti, Annamaria Tomasso, Diana Giannarelli, Lydia Scarfò et autres
0 citationsBlood
Transdermal Fentanyl in Patients with Cachexia—A Scoping Review
Andrea Carlini, Emanuela Scarpi, Carla Bettini, Andrea Ardizzoni et autres
6 citationsCancers
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.